Vaxxinity Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Mei Hu
Chief executive officer
US$1.4m
Total compensation
CEO salary percentage | 22.6% |
CEO tenure | 10.8yrs |
CEO ownership | 4.4% |
Management average tenure | less than a year |
Board average tenure | 3.3yrs |
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$1m | US$308k | -US$57m |
Sep 30 2023 | n/a | n/a | -US$66m |
Jun 30 2023 | n/a | n/a | -US$72m |
Mar 31 2023 | n/a | n/a | -US$75m |
Dec 31 2022 | US$532k | US$400k | -US$75m |
Sep 30 2022 | n/a | n/a | -US$103m |
Jun 30 2022 | n/a | n/a | -US$114m |
Mar 31 2022 | n/a | n/a | -US$123m |
Dec 31 2021 | US$13m | US$400k | -US$137m |
Sep 30 2021 | n/a | n/a | -US$102m |
Jun 30 2021 | n/a | n/a | -US$88m |
Mar 31 2021 | n/a | n/a | -US$68m |
Dec 31 2020 | US$348k | US$335k | -US$40m |
Compensation vs Market: Mei's total compensation ($USD1.36M) is above average for companies of similar size in the US market ($USD650.80K).
Compensation vs Earnings: Mei's compensation has increased whilst the company is unprofitable.
CEO
Mei Hu (41 yo)
10.8yrs
Tenure
US$1,360,331
Compensation
Ms. Mei Mei Hu, J.D., serves as Chief Executive Officer of Vaxxinity, Inc. and has been its President has been its Director since 2014 and served as its President until June 2022. She Co-Founded Vaxxinity,...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Executive Chairman of the Board | 10.2yrs | US$1.29m | 3.13% $ 794.6 | |
Co-Founder | no data | US$1.36m | 4.35% $ 1.1k | |
Chief Legal | 1.1yrs | US$823.41k | no data | |
Chief Accounting Officer | less than a year | no data | no data | |
Chief Scientific Officer | less than a year | no data | no data | |
Chief of Staff | no data | no data | no data | |
Chief Regulatory Officer | less than a year | no data | no data |
0.8yrs
Average Tenure
46yo
Average Age
Experienced Management: VAXX's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Executive Chairman of the Board | 10.2yrs | US$1.29m | 3.13% $ 794.6 | |
Co-Founder | 10.8yrs | US$1.36m | 4.35% $ 1.1k | |
Independent Director | 2.8yrs | US$264.15k | 0% $ 0 | |
Non-Employee Independent Director | 3.7yrs | US$233.94k | 1.59% $ 404.0 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 1.8yrs | US$259.99k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Lead Independent Director | 1.8yrs | US$270.62k | 0.026% $ 6.6 |
3.3yrs
Average Tenure
60yo
Average Age
Experienced Board: VAXX's board of directors are considered experienced (3.3 years average tenure).